机译:Similar clinical benefits from below‐target and target dose enalapril in patients with heart failure in the SOLVD Treatment trial
Veterans Affairs Medical CenterWashington,DC,USA;
University of CaliforniaLos Angeles,CA,USA;
Stony Brook UniversityStony Brook,NY,USABrigham and Women's Hospital Heart and Vascular CenterBoston,MA,USAAttikon University HospitalAthens,GreeceUniversity of CaliforniaSan Francisco, Fresno,CA,USAUniversity of Pittsburgh and VA Pittsburgh Healthcare SystemPittsburgh,PA,USAUniversité de MontréalMontreal,CanadaSt Paul General HospitalThessaloniki,GreeceHippocration HospitalThessaloniki,GreeceUniversity of Alabama at BirminghamBirmingham,AL,USAUniversity of CaliforniaSan Francisco,CA,USAWestchester Medical Center and New York Medical CollegeValhalla,NY,USADepartment of Veterans AffairsGeriatrics and Extended CareWashington,DC,USADivision of Cardiology and Metabolism ‐ Heart Failure, Cachexia and Sarcopenia, Department ofUniversity of MichiganAnn Arbor,MI,USA;
ACE inhibitors; Target dose; Enalapril; Placebo; Heart failure;